David R. Walt - 02 Jan 2025 Form 4 Insider Report for Quanterix Corp (QTRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jan 2025, 17:58:37 UTC
Prior SEC filing
17 Sep 2024
Next SEC filing
03 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian Keane, as Attorney-in-Fact

Key filing fact

David R. Walt filed Form 4 for Quanterix Corp (QTRX) on 06 Jan 2025.

Key facts

  • This page summarizes David R. Walt's Form 4 filing for Quanterix Corp (QTRX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Jan 2025, 17:58.

Change

  • Previous filing in this sequence was filed on 17 Sep 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTRX transaction

Common Stock

Award

Transaction value
$0
Shares
+7,435
Change %
+0.5%
Price
$0.000000
Shares after
1,494,777
Date
02 Jan 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QTRX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+15,821
Change %
Price
$0.000000
Shares after
15,821
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,821
Exercise price
$10.76
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units that vest as to 100% of the shares on December 31, 2025 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

Footnote F2

Includes 7,435 restricted stock units.

Footnote F3

Represents non-qualified stock option to purchase 15,821 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .